SEP 09, 2018 01:53 AM PDT

Synthetic DNA Technology for Therapeutic Molecule Delivery

WRITTEN BY: Nouran Amin

Image Source: Greater Kashmir

Synthetic DNA technology was used to engineer a novel eCD4-Ig anti-HIV agent while enhancing its potency ‘in vivo’ which was done by researchers at The Wistar Institute. Such technology has provided a simple strategy for building complex therapeutics for infectious agents as well as for diverse implications in drug delivery. The development was published online in the journal EBio Medicine.

The need for delivering complex therapeutic molecules has been a critical challenging. One such challenge is the development of a safe and effective HIV vaccine. Researchers are seeking to address these issues by exploring ‘passive immunization of laboratory-produced immunoadhesins’ in addition to traditional gene therapy methods for delivery of complex therapeutic molecules. "These complex therapeutics are difficult to deliver through traditional strategies and achieving full activity in vivo using DNA technology is also challenging," said lead researcher David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Professor in Cancer Research at The Wistar Institute. "We demonstrated that a combination of plasmids can be designed to produce a novel protein as well as its modifying enzyme, allowing them to collocate with each other and create a highly functional immunoadhesin."

Image Source: Medgadget

The technology consists of electroporation of synthetic DNA (DNA/EP) that involves the application of small, controlled directional electric currents placed inside the skin or muscle that facilitates the optimal uptake of DNA molecules as well as the local production of the DNA-encoded proteins. The technology then was able to achieve robust and long-term in vivo expression. In a mouse model, the single injection of the synthetic DNA formula has produced a functional eCD4-Ig for several months. Previous research has shown that a particular modification of the immunoadhesins, called sulfation, favored their binding to the HIV envelope. Thus, co-expression of an enzyme called ‘TPST2’ was able to occur and was crucial to increase the efficacy of the anti-HIV potency of the produced eCD4-Ig. "This is the first report on the use of synthetic DNA to encode an enzyme that can effectively carry out its activity and modulate biological functions of a target protein with high efficiency in vivo," said Weiner.

The research has advanced the field of HIV immunization and opening the doors for further applications for in vivo delivery of biologics.

Source: The Wistar Institute

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 25, 2018
Technology
JUL 25, 2018
An Alogrithm That Can Fight Crime
According to a study published in the journal Computational Statistics and Data Analysis, a recent algorithm created by the University of Surrey and Georgi...
JUL 25, 2018
Cell & Molecular Biology
JUL 25, 2018
Super-resolution Microscope Provides Insight Into Alzheimer's Plaques
Alzheimer's disease is the sixth leading cause of death in the US....
AUG 12, 2018
Technology
AUG 12, 2018
Smart Wristband Monitors Health
Engineers at Rutgers University-New Brunswick have recently developed a wireless connection wristband for smartphone compatibility that can monitor health....
SEP 18, 2018
Cell & Molecular Biology
SEP 18, 2018
Visualizing the Organization of Human Cells With Machine Learning
Instead of fluorescent labeling, scientists found a way to use computers to identify cellular structures....
SEP 28, 2018
Health & Medicine
SEP 28, 2018
Are Smartphones and Electronics Responsible for Teen Sleep Issues?
Chances are if you see a teenager, their face is practically glued to a screen. The latest industry numbers show that 95% of teens own or have access to a...
OCT 05, 2018
Health & Medicine
OCT 05, 2018
A Caterpillar Robot for Drug Delivery? Ya, That's a Thing
Drug delivery is a significant part of medical research since a drug cannot work if it cannot access the part of the body where it's needed. Nanotechno...
Loading Comments...